Facility #1

Kelowna, British Columbia V1Y 1Z9

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Insomnia Disorder

Studies at this site

• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease — Stopped early
• Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2) — Completed